Dementia vs Alzheimer’s Disease: Why Finding the Cause Changes the Treatment Plan

A daughter sits in a clinic waiting room holding a notebook. In it she has written, in three different pens over eight months, the things her father has forgotten: the route to a shop he visited for thirty years, the name of his neighbor’s dog, whether he had already eaten lunch. She has come with one question ready. Is it dementia, or is it Alzheimer’s?

The doctor’s answer surprises her: it may be both, and the more useful question is what is causing it. That distinction sits at the heart of any honest conversation about dementia vs Alzheimer’s treatment. One word describes what is happening; the other names a reason it might be happening. Only the reason tells a care team what to do next.

This explainer walks through how clinicians tell the causes apart, why the treatment plan changes with each answer, what the weeks after a diagnosis usually look like, and how families can support someone whose memory is slipping without losing sight of the person behind it.

What's the difference between dementia and Alzheimer's disease?

Think of dementia the way you think of a fever. A fever is not a disease; it is a sign that something else is going on. Dementia works the same way. It is a clinical syndrome, meaning a recognizable pattern of problems with memory, reasoning, language or behavior that has become severe enough to interfere with everyday life. Something has to be causing it, and there are dozens of candidates.

Alzheimer’s disease is the most frequent of those candidates. The World Health Organization estimates it contributes to 60-70 percent of dementia cases worldwide, out of more than 55 million people currently living with dementia and nearly 10 million new cases each year. So the overlap is large but not total. Every person with Alzheimer’s dementia has dementia, yet a meaningful minority of people with dementia do not have Alzheimer’s at all.

Where does the confusion come from? Partly history. For decades, families and even many doctors used the two words interchangeably, and the brain changes could only be confirmed after death. That has shifted. Modern assessment can often distinguish Alzheimer’s from other causes during life, using the pattern of symptoms, brain imaging and, increasingly, biological markers measured in spinal fluid or blood.

The distinction is not academic. A person whose forgetfulness comes from a series of small strokes needs a plan built around blood pressure, cholesterol and clot prevention. A person with Lewy body dementia can be seriously harmed by a medicine that is routine for someone else. A person with an underactive thyroid or a vitamin deficiency may not have a progressive brain disease at all. The word dementia opens the door; the cause tells the team which room to walk into.

Dementia vs Alzheimer's treatment: why the cause decides the plan

Once a care team suspects dementia, the work of treatment cannot really begin until they have a working answer about why. The reason is mechanical, not bureaucratic. Different causes damage the brain in different ways, and the tools available act on those specific mechanisms.

Alzheimer’s disease involves two abnormal proteins, amyloid and tau, that build up and disrupt communication between nerve cells, alongside a fall in acetylcholine, a chemical messenger involved in memory. The medicines used in Alzheimer’s aim squarely at those features: some slow the breakdown of acetylcholine, another steadies an overactive signaling pathway, and newer antibody therapies target amyloid itself.

Vascular dementia arises when blood supply to parts of the brain is reduced or cut off, often through small strokes. None of the Alzheimer’s-specific medicines address blocked or leaking vessels. The treatment plan instead borrows from cardiology: controlling blood pressure, treating diabetes and cholesterol, stopping smoking and, where a clinician judges it appropriate, preventing clots. According to the NHS, these steps aim to prevent further vascular damage rather than reverse what has already occurred.

Lewy body dementia involves deposits of a protein called alpha-synuclein and produces fluctuating alertness, vivid visual hallucinations and movement changes resembling Parkinson’s disease. People with this condition can react severely to antipsychotic medicines, which is why identifying it before a crisis matters so much.

Frontotemporal dementia typically strikes earlier, often between 45 and 65 according to the NHS, and changes personality and language before memory. There is no disease-specific medicine; care centers on behavioral strategies, speech and language therapy and family support.

Each of these is a different road. Naming the cause is what lets a team choose the right one, and it is why guideline bodies treat a thorough diagnostic work-up as the first act of treatment rather than a preliminary to it.

How is Alzheimer's diagnosed? What actually happens in the work-up

There is no single test. Diagnosis is a process of building a picture from several angles and, just as importantly, ruling other things out.

It usually starts with a conversation. The clinician asks the person and, with permission, someone who knows them well about what has changed, when it began, and how quickly. Gradual, steady decline over months to years points one way; sudden or stepwise change points another. A review of every medicine being taken follows, because some common drugs cloud thinking, particularly in older adults.

Next comes a brief cognitive assessment, a structured set of questions and tasks that samples memory, attention, language and orientation. These screening tools take ten to fifteen minutes and cannot diagnose anything on their own; they simply show where difficulties cluster. The Mayo Clinic notes that more detailed neuropsychological testing may be added when the picture is unclear or the person is younger than expected.

Blood tests check for treatable contributors such as thyroid problems, low vitamin B12 or folate, kidney or liver disorders and infection. A brain scan, usually CT or MRI, looks for strokes, tumors, bleeding, fluid build-up or the pattern of shrinkage that suggests one dementia type over another.

In specialist settings, biomarker tests may follow. A lumbar puncture can measure amyloid and tau in the fluid around the spinal cord, and specialized PET scans can show these proteins in the living brain. Blood-based markers are emerging, though they are still being validated for routine use. Confirming amyloid is now a prerequisite before anyone is considered for anti-amyloid therapy, which is one concrete way the diagnostic step shapes treatment.

Referral to a memory clinic or neurologist is common when the diagnosis is uncertain, symptoms are unusual or the person is under 65. Expect the whole process to take weeks rather than days.

The main types of dementia and how their treatment differs

Families often ask for a chart, and this is one place where a table genuinely earns its space. The rows below cover the four most common progressive causes plus the mixed picture that becomes more frequent with age. Symptoms listed are typical patterns, not a checklist; many people show features from more than one column.

Type	What is happening in the brain	Typical early pattern	What treatment focuses on
Alzheimer’s disease	Amyloid plaques, tau tangles, loss of acetylcholine	Gradual memory loss for recent events; word-finding trouble; misplacing things	Cholinesterase inhibitors; memantine; anti-amyloid antibodies in selected early cases; structured support
Vascular dementia	Reduced blood flow from strokes or small-vessel disease	Slowed thinking, trouble planning; may worsen in steps	Blood pressure, cholesterol, diabetes and smoking control; stroke prevention as judged by the clinician
Lewy body dementia	Alpha-synuclein deposits	Fluctuating alertness, visual hallucinations, stiffness or tremor, acting out dreams	Careful avoidance of antipsychotics; cholinesterase inhibitors sometimes used; movement and sleep support
Frontotemporal dementia	Degeneration of frontal and temporal lobes	Personality change, loss of empathy, impulsivity or progressive language loss, often before 65	Behavioral strategies, speech therapy, caregiver support; no disease-specific medicine
Mixed dementia	Two or more processes together, most often Alzheimer’s plus vascular	Overlapping features	Combines approaches from each contributing cause

Notice how little the right-hand column repeats itself. Cholinesterase inhibitors appear in two rows, absent in two others. Blood-vessel management dominates one row and merely supports the rest. The antipsychotic warning belongs to Lewy body dementia specifically. A plan written before the cause was known would be guessing at most of these cells.

Can dementia be treated or reversed? The mimics that must be ruled out

Most progressive dementias cannot be reversed, and honest care starts by saying so. But a smaller group of conditions produce dementia-like symptoms that can improve substantially or resolve entirely when the underlying problem is treated. Missing one of these is the single most consequential error a diagnostic process can make, which is why the blood tests and scan described above are never skipped.

Depression in older adults can flatten concentration, slow thinking and cause the person to answer “I don’t know” to questions they could once handle. Clinicians sometimes call this pseudodementia. Treating the depression often lifts the cognitive fog along with the mood.

Medicines are another frequent culprit. Drugs with anticholinergic effects, a property shared by some bladder, allergy, sleep and stomach medicines, block the same chemical messenger that Alzheimer’s depletes. Sedatives and strong painkillers add to the problem. A careful medication review, led by the prescribing clinician, is a treatment in itself.

Metabolic and nutritional problems belong on the list: an underactive thyroid, low vitamin B12, kidney or liver disease, and severe dehydration. So do untreated sleep apnea, heavy alcohol use, chronic subdural bleeding after a minor head injury, and normal pressure hydrocephalus, a build-up of fluid in the brain that produces the recognizable trio of walking difficulty, urinary urgency and cognitive slowing, and which can respond to a surgical shunt.

Then there is delirium, an acute confusional state that develops over hours or days, usually triggered by infection, surgery, pain or a new medicine. MedlinePlus describes it as a medical emergency that is often reversible with treatment of the cause. Delirium and dementia frequently coexist, and a sudden worsening in someone with known dementia should raise the question of delirium first.

The point is not false hope. It is that a proportion of people walking into a memory clinic will leave with a problem that can be managed or corrected, and the only way to find them is to look.

Dementia vs Alzheimer's treatment: what the medicines actually do

Two established medicine classes and one newer class are used specifically in Alzheimer’s disease. Understanding what each one does, and does not do, helps families set realistic expectations. Whether any of them is appropriate for a particular person is a decision for the prescribing clinician.

Cholinesterase inhibitors (the generic names are donepezil, rivastigmine and galantamine) slow the breakdown of acetylcholine, the memory-related messenger that Alzheimer’s depletes. They do not stop the underlying disease. According to the NHS, they are typically offered for mild to moderate Alzheimer’s and may also be considered in Lewy body dementia and in mixed dementia with an Alzheimer’s component. Their effect is generally described as a modest, temporary steadying of symptoms; the disease continues underneath. Common side effects include nausea, reduced appetite and a slowed heart rate, which is why a clinician checks pulse and history first.

Memantine works differently. It dampens excess activity of glutamate, another brain messenger that can damage nerve cells when overactive. The NHS lists it for moderate to severe Alzheimer’s, and for people who cannot tolerate cholinesterase inhibitors. It may be used alongside them in later stages.

Anti-amyloid antibody therapies are given by intravenous infusion and are designed to clear amyloid from the brain. In clinical trials summarized by the Mayo Clinic, they modestly slowed the rate of decline over roughly eighteen months in people with early-stage Alzheimer’s whose amyloid had been confirmed by scan or spinal fluid testing. They carry a specific risk of brain swelling or small bleeds, known as ARIA, which requires regular MRI monitoring, and eligibility depends on stage, genetics and other health factors. Availability varies by health system, and any conversation about them belongs with a specialist team.

None of these is used for vascular dementia on its own, and none reverses damage already done. That honesty is part of good treatment.

Types of dementia treatment beyond pills: the care that carries most of the weight

If you removed every medicine from a dementia care plan, most of the plan would still be standing. Non-drug approaches are not a consolation prize; guideline bodies place them at the center of care for every dementia type, and they are the only disease-agnostic tools available.

Cognitive stimulation involves structured group or one-to-one activities that exercise memory, language and problem-solving through conversation, games and reminiscence. The NHS recommends it for people with mild to moderate dementia of any cause.

Occupational therapy looks at the home and daily routines and adapts them: labeling cupboards, simplifying the kitchen, installing grab rails, arranging a clear path to the bathroom at night. Small environmental changes can preserve independence for months longer than they otherwise might.

Physical activity supports mood, sleep, balance and cardiovascular health, all of which matter in every form of dementia and especially in vascular disease. Walking, chair-based exercise and gardening all count.

Managing hearing and vision is underrated. Uncorrected hearing loss makes conversation exhausting and isolates people; a working hearing aid or updated glasses reduces confusion and frustration in ways that no tablet can.

Behavioral and psychological symptoms, such as agitation, wandering or evening restlessness, are first approached by looking for triggers: pain, constipation, infection, boredom, noise, a change in routine. Music, familiar photographs, daylight exposure and predictable schedules are first-line strategies. Antipsychotic medicines are reserved for severe distress or danger, used at the lowest effective level for the shortest time, and avoided wherever possible in Lewy body dementia.

Caregiver support is treatment for the person with dementia too. Education, respite and peer groups reduce carer burnout, and a rested carer is the most protective factor most people with dementia have.

Who is usually offered which treatment, and who is asked to wait

Clinicians do not hand out the same plan to everyone who hears the word dementia. Several factors steer the recommendation, and understanding them makes the decisions feel less arbitrary.

Stage of illness comes first. Cholinesterase inhibitors are typically introduced in mild to moderate Alzheimer’s; memantine is generally reserved for moderate to severe stages. Anti-amyloid antibodies are considered only in early disease, meaning mild cognitive impairment or mild dementia with confirmed amyloid. Someone at a later stage would not be a candidate, not because they are less deserving but because the trials did not include them and the risk-benefit balance is unknown.

Confirmed cause is second. A person whose scans show mostly vascular damage, with no amyloid evidence, is usually steered toward vascular risk management rather than Alzheimer’s medicines. A person with clear Lewy body features has antipsychotics struck from the list before anything is added.

Overall health shapes the rest. A slow heart rhythm, active stomach ulcers or severe asthma may make cholinesterase inhibitors unwise. Blood-thinning medicine, a history of brain bleeding, or a particular genetic profile can rule out anti-amyloid therapy, since these raise the risk of ARIA.

Who is asked to wait? People whose cognitive changes may be explained by something reversible are usually asked to treat that first and be reassessed. Someone with mild cognitive impairment that has not progressed to dementia is often monitored at intervals rather than started on Alzheimer’s medicines, because many such people never develop dementia. And anyone whose diagnosis is still uncertain is asked to complete the work-up before committing to a treatment path, precisely because the wrong path can cause harm.

Waiting, in this context, is not neglect. It is the team refusing to guess.

What the first weeks after a dementia diagnosis usually look like

The appointment where a diagnosis is named tends to blur. What follows is more predictable than most families expect.

In the first week or two, the priority is information and paperwork. The clinician or a dementia nurse usually explains the specific diagnosis, what it means for the coming years in broad terms, and which local support services exist. Families are encouraged to gather documents and consider legal arrangements such as powers of attorney and advance care planning while the person can still take part fully. This is uncomfortable and also one of the most valuable things done early.

If a medicine is started, the first few weeks are about tolerability rather than benefit. Cholinesterase inhibitors are usually introduced gradually under the prescriber’s schedule, and side effects like nausea or vivid dreams, when they appear, tend to show up in this window. A follow-up review is commonly arranged a few months in, at which point the clinician and family judge together whether the medicine seems to be helping and whether to continue. The NHS notes that benefit is often modest and that treatment is periodically reviewed rather than assumed to be lifelong.

For vascular dementia, the early weeks may involve tightening blood pressure and cholesterol control, a driving assessment, and referral for stroke risk review.

For anti-amyloid therapies, where offered, the lead-in is longer: genetic testing, baseline MRI and confirmation of amyloid status typically precede the first infusion, and MRI checks continue at set points during treatment.

Across all types, occupational therapy and cognitive stimulation referrals are made, driving is discussed and often reported to the relevant licensing authority, and the person and carer are usually pointed toward a support group. By the end of the second month, most families have a named contact and a first review date, which is the shape a plan takes.

How to deal with people with dementia and Alzheimer's: communication that works

The phrase people type into search engines is “how to deal with,” but the more useful frame is how to keep company with someone whose brain is changing. A few evidence-informed habits make an outsized difference.

Slow down and shorten. Offer one idea per sentence and one question at a time. “Would you like tea or coffee?” is easier than “What do you want to drink?” because it supplies the options rather than demanding recall.

Approach from the front, at eye level, and say who you are. Facial recognition and peripheral awareness both fade; appearing suddenly from the side startles people and can trigger a defensive reaction that looks like aggression but is fear.

Do not argue with a mistaken belief. If your mother insists she needs to collect the children from school, correcting her produces distress without producing understanding. Acknowledge the feeling underneath, redirect gently, and let the moment pass. Clinicians sometimes call this validation rather than confrontation.

Resist quizzing. “Do you remember who this is?” puts someone on the spot and sets them up to fail. “This is Sam, your grandson, he’s come to see you” gives the information as a gift.

Watch for unmet needs behind behavior. Pacing, calling out or refusing care are frequently signals of pain, a full bladder, hunger, cold, boredom or overstimulation. Because the person may not be able to name the problem, the carer becomes the detective.

Keep routines steady and the environment calm: consistent mealtimes, good daylight, reduced background noise, familiar objects within view. Music from the person’s youth often reaches parts of memory that conversation cannot.

And protect yourself. Carer exhaustion is a medical issue with medical consequences for both people. Accepting respite is part of the care plan, not a departure from it.

How long can someone with dementia live alone? Safety and independence

There is no stage on a chart that says “move now.” The honest answer is that many people live alone safely in the early stages, some for years, and the tipping point is set by specific risks rather than a diagnosis or a date.

Mayo Clinic notes that people with Alzheimer’s live on average three to eleven years after diagnosis, and some far longer; a large share of that time is spent with mild to moderate symptoms in which independent living remains realistic with support. Vascular and Lewy body dementias follow different curves, and Lewy body fluctuations in particular can make a good day look deceptively reassuring.

Rather than asking how long, families and clinicians look at concrete domains. Can the person manage medicines reliably, or are pills being doubled or missed? Is food in the fridge spoiling? Are bills paid, or are there notices and unfamiliar charges suggesting financial exploitation? Have there been kitchen fires, wandering episodes, falls, or occasions of getting lost on a familiar route? Is the person able to summon help and recognize an emergency? Is the home warm, and is hygiene maintained?

Occupational therapists formally assess these areas and suggest supports: pill organizers or automated dispensers, cooker shut-off devices, door sensors, daily check-in calls, meal deliveries, a wearable pendant alarm, and simplified finances with a trusted person as co-signatory. Each of these can extend independent living by addressing the specific failure point rather than the whole life.

The signs that living alone is no longer safe are behavioral, not calendar-based: repeated wandering or getting lost, significant weight loss, a fall with no ability to call for help, or a fire or flood incident. When those appear, the conversation shifts to increased in-home care or a move, and it should involve the person themselves as fully as their capacity allows.

What people often get wrong about dementia and Alzheimer's

Myths cluster around this topic more than most, partly because so many families face it and partly because the language is muddled. A few corrections, each grounded in mainstream evidence.

“Dementia is just old age.” Aging brings slower recall and occasional word-finding pauses; it does not bring the loss of daily function that defines dementia. The WHO is explicit that dementia is not an inevitable consequence of aging, and a growing body of research points to modifiable risk factors such as hearing loss, hypertension, smoking, physical inactivity and social isolation that influence risk across the lifespan.

“If it’s not Alzheimer’s, it’s not serious.” Vascular, Lewy body and frontotemporal dementias are progressive and life-altering. Their treatment differs, not their gravity.

“Memory loss means Alzheimer’s.” Frontotemporal dementia often begins with personality change and intact memory. Lewy body dementia may open with hallucinations or sleep disturbance. Assuming Alzheimer’s can delay the right plan.

“The medicines will bring her back.” Current Alzheimer’s medicines steady symptoms modestly or slow decline modestly. None restores lost function, and expecting otherwise sets families up for grief on top of grief.

“Nothing can be done, so why get a diagnosis?” A diagnosis identifies reversible causes, unlocks support services, allows legal and financial planning while the person can participate, and prevents harmful prescribing. That is a great deal.

“Supplements protect the brain.” Trials of vitamin E, ginkgo, fish oil and various “brain” formulas have not shown convincing prevention or treatment benefit; the NIH Office of Dietary Supplements summarizes the evidence as insufficient. Correcting a true deficiency is different from taking supplements in hope.

“A brain-training app is enough.” Cognitive stimulation is helpful; commercial apps have not demonstrated that gains transfer to daily life. Social engagement and physical activity have better evidence.

Questions to ask your care team

The most useful appointments are the ones where the family arrives with questions written down. These are the ones experienced clinicians say they wish more people asked.

• What type of dementia do you think this is, and how confident are you? What would change your mind?
• Have reversible causes been checked: thyroid, B12, medicines, mood, sleep apnea, hearing?
• Is there anything on the current medicine list that might be worsening thinking, and should it be reviewed?
• Which treatments are appropriate for this specific type and stage, and which are not? Why?
• If a medicine is started, what should we expect it to do, what side effects should we watch for, and when will it be reviewed?
• Is there a reason to consider or avoid anti-amyloid therapy in this case, and what would assessment involve?
• Are any medicines dangerous for this type of dementia, and how do we make sure other clinicians know?
• What non-drug support is available locally: cognitive stimulation, occupational therapy, carer education?
• Should driving stop, and who assesses that?
• What legal and financial planning should we do now, while decisions can still be shared?
• What signs should prompt an urgent call rather than waiting for the next review?
• Who is our named contact, and how do we reach them?

Take notes or ask permission to record the conversation. Bring someone else if you can. Ask the clinician to repeat anything unclear; a good team would rather explain twice than have you leave with a wrong impression. And if the answer to the first question is “we’re not sure yet,” treat that as a sign of care rather than uncertainty for its own sake. A team willing to say so is a team unlikely to guess with your family’s treatment.

When to call your doctor: red flags in dementia and Alzheimer's

Dementia usually changes slowly. When it changes fast, something else is often going on, and that something is frequently treatable. Contact the care team promptly, or seek emergency care where indicated, in the following situations.

Seek emergency care if there is sudden confusion, weakness or numbness on one side, facial drooping, slurred speech or loss of vision, since these may indicate a stroke, which is time-critical. The same applies to a seizure, a fall with a head injury (especially on blood-thinning medicine), a loss of consciousness, or severe difficulty breathing.

Call the same day if confusion has worsened noticeably over hours to a couple of days, if the person is suddenly much drowsier or much more agitated than usual, is seeing or hearing things that are new, or is unable to recognize familiar people when they could yesterday. This pattern suggests delirium, and infection, dehydration, constipation, pain or a new medicine are common triggers.

Contact the team within a few days if there is a fever, new incontinence, refusal to eat or drink, new or worsening pain, unexplained weight loss, a fall without injury, or a marked change in mood such as persistent tearfulness or expressions of hopelessness.

Report medicine-related concerns promptly: fainting or a very slow pulse after starting a cholinesterase inhibitor, persistent vomiting, or new headaches, unsteadiness or visual changes in someone receiving anti-amyloid infusions, which can be early signs of ARIA.

Finally, carers should call on their own behalf if they feel unable to cope, are not sleeping, or notice their own health failing. Every decision about investigation and treatment sits with the treating team, but the team can only act on what it is told, and the person who notices the change first is almost always a family member.

Frequently asked questions

How can you tell if it's dementia or Alzheimer's?

Dementia describes the symptoms; Alzheimer’s is one possible cause, so a person can have both at once. Clinicians distinguish Alzheimer’s from other causes by the pattern of symptoms, especially gradual loss of recent memory, together with blood tests, brain imaging and sometimes spinal fluid or PET biomarkers that show amyloid and tau. A sudden or stepwise course, early hallucinations or personality change point toward vascular, Lewy body or frontotemporal causes instead.

What is the best treatment for Alzheimer's and dementia?

There is no single best treatment, because the right plan depends on the cause and stage. Alzheimer’s may be managed with cholinesterase inhibitors, memantine and, in early confirmed cases, anti-amyloid antibodies; vascular dementia centers on blood-vessel risk control; all types rely heavily on cognitive stimulation, occupational therapy, exercise and carer support. The treating team weighs these options against the person’s health, and none of the current medicines reverses existing damage.

What is the difference between dementia and Alzheimer's in simple terms?

Dementia is the umbrella; Alzheimer’s is the most common thing under it. Dementia means memory and thinking have declined enough to affect daily life, whatever the reason. Alzheimer’s disease is a specific brain disease involving amyloid and tau proteins that causes most, but not all, dementia. Other causes include strokes, Lewy body disease and frontotemporal degeneration, and each is treated differently, which is why the label matters.

How is Alzheimer's diagnosed without a brain biopsy?

Alzheimer’s is diagnosed clinically, using history from the person and family, cognitive testing, blood tests to exclude other causes, and MRI or CT imaging. In specialist clinics, amyloid and tau can be measured in spinal fluid or seen on PET scans, which supports the diagnosis during life. Blood-based markers are emerging but not yet standard. Confirming amyloid is required before anti-amyloid therapy is considered.

Can dementia be treated if it is caught early?

Some causes can be treated or reversed, and early assessment is how they are found. Depression, thyroid disease, vitamin deficiencies, medicine side effects, sleep apnea and normal pressure hydrocephalus can all produce dementia-like symptoms that improve with treatment. Progressive dementias such as Alzheimer’s cannot currently be reversed, but early diagnosis allows symptom-steadying medicines, planning, safety measures and access to support while the person can still participate in decisions.

How long can someone with dementia live alone?

Many people live alone safely during the early stages, sometimes for years, and there is no fixed timeline. The decision rests on specific risks: managing medicines, eating adequately, handling money, avoiding fires, not wandering and being able to call for help. Occupational therapy assessments and supports such as automated pill dispensers, cooker shut-offs and daily check-ins can extend independence. Repeated wandering, falls or a fire incident signal that more support is needed.

How do you deal with someone with dementia who gets angry or agitated?

Look first for an unmet need such as pain, a full bladder, hunger, cold, noise or fear, because agitation is often communication. Approach calmly from the front, speak slowly in short sentences, avoid arguing with mistaken beliefs, and redirect to a familiar activity or music. Persistent or dangerous agitation should be reviewed by the care team, who will check for delirium and infection before considering medicines, which are used cautiously and avoided where possible in Lewy body dementia.

What are the types of dementia treatment that do not involve medicine?

Cognitive stimulation therapy, occupational therapy to adapt the home, regular physical activity, correcting hearing and vision, structured daily routines, reminiscence and music, and caregiver education and respite are the core non-drug treatments. Guideline bodies recommend them for all dementia types, and for frontotemporal dementia they are the main approach, since no disease-specific medicine exists. Managing cardiovascular risk factors is also central in vascular dementia.

Do Alzheimer's medicines stop the disease from getting worse?

No current medicine stops Alzheimer’s. Cholinesterase inhibitors and memantine act on brain chemistry to steady symptoms modestly and temporarily while the disease continues. Anti-amyloid antibodies, in trials, slowed the rate of decline modestly over about eighteen months in early-stage disease with confirmed amyloid; they do not restore lost function and carry risks that require MRI monitoring. Expectations should be set with the prescribing clinician.

Why do doctors ask about medicines when someone has memory problems?

Because several common medicines can impair thinking, especially in older adults, and stopping or changing them under a clinician’s guidance can improve symptoms. Drugs with anticholinergic effects, found in some bladder, allergy, sleep and stomach medicines, block the same messenger Alzheimer’s depletes. Sedatives and strong painkillers add to confusion. A medication review is one of the few dementia treatments that can produce noticeable improvement, and it should always be done by the prescriber.

References

• World Health Organization – Dementia fact sheet
• NHS – Alzheimer's disease: Treatment
• MedlinePlus – Dementia
• Cleveland Clinic – Dementia: Symptoms, types, causes and treatment

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.